CIK 0001388320 · Non-accelerated filer<br>Smaller reporting company
Actinium Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ATNM
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 880378336
- Phone
- (646) 677-3870
- Business address
- 100 PARK AVE., 23RD FLOOR, NEW YORK, NY, 10017
- Former names
- Cactus Ventures, Inc.
- 4 Grant or award Interim CFO acquired 10,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Regulation FD disclosure · Other events
- DEF 14A Proxy Proxy Statement
- UPLOAD Other SEC-generated Letter
- PRER14A Other PRER14A
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 424B3 Offering Prospectus
- 8-K Event Regulation FD disclosure · Other events
- 10-Q Report Quarterly Report
- 424B3 Offering Prospectus
- 3 Insider Initial Statement of Ownership
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Executive or director change · Other events
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1/A Offering Registration Statement
Page 21 of 26 · 511 filings